Hetero Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is NEBIVOLOL HYDROCHLORIDE, with a corresponding US DMF Number 25296.
Remarkably, this DMF maintains an Active status since its submission on September 12, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 04, 2013, and payment made on December 05, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II